The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...
The outlook for the neuroblastoma treatment market is optimistic, fueled by progress in targeted therapies and immunotherapies. GD2-targeted immunotherapy is increasingly being incorporated into...
"Screen-Free Sleep" movement takes to the streets to address America's youth sleep crisis
NEW YORK, Aug. 14, 2025 /PRNewswire/ -- In a bold wake-up call...
iPETcertum™ by Claritas, Developed with Cutting-Edge Technology for Enhancement, Automated Segmentation and Accurate Quantification in PET, PET-CT/MRI Scan
Integration marks the latest milestone in Cox Automotive's continued investment in delivering the industry's most complete view of every vehicle across retail and wholesale.
ATLANTA...
LOS ANGELES, Aug. 10, 2025 (GLOBE NEWSWIRE) -- RadNet, Inc. (NASDAQ: RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 405 owned and operated outpatient imaging centers, today reported financial results for its second quarter of 2025.
New indication of SonoVue® supports non-invasive assessment of female infertility through contrast-enhanced ultrasound in China
MILAN, Aug. 5, 2025 /PRNewswire/ -- Bracco Imaging, a global...
The newly FDA-cleared uMR® Ultra and the uOmniscan™ are the first major announcements leading into the AHRA Annual Meeting in Las Vegas.
HOUSTON, Aug. 3, 2025...